ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiretroviral Agent Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-0U13105
Home | Market Reports | Health| Reproductive Health
Global Antiretroviral Agent Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Antiretroviral Agent Market Research Report 2025

Code: QYRE-Auto-0U13105
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ViiV Healthcare
Gilead Sciences
GlaxoSmithKline PLC
Merck Sharp and Dohme
Bristol–Myers Squibb
Janssen Pharmaceuticals
Pfizer Inc
Boehringer Ingelheim
AbbVie
Genentech Inc
Mylan NV

Antiretroviral Agent Market Size

The global market for Antiretroviral Agent was valued at US$ 51470 million in the year 2024 and is projected to reach a revised size of US$ 65260 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Antiretroviral Agent Market

Antiretroviral Agent Market

The clinical use of antiretroviral agents involves a pathogenesis-based, combination treatment approach. Increase in the number of chronic diseases, HIV infections will lead to more medicinal development. The surge for anti-resistant medicines has been in demand. In addition as monoclonal antibodies demand increases, the growth for the antiretroviral (ARV) agents market will spike its rate, demand in personalized medicines has increased bio production, accelerating antiretroviral (ARV) demand.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiretroviral Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiretroviral Agent.
The Antiretroviral Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiretroviral Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiretroviral Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiretroviral Agent Market Report

Report Metric Details
Report Name Antiretroviral Agent Market
Accounted market size in year US$ 51470 million
Forecasted market size in 2031 US$ 65260 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Nucleoside Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • HIV Integrase Strand Transfer Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Entry Inhibitors—CCR5 Co-Receptor Antagonist
  • Fusion Inhibitors
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ViiV Healthcare, Gilead Sciences, GlaxoSmithKline, Merck Sharp and Dohme, Bristol-Myers Squibb, Janssen Pharmaceuticals, Pfizer, Boehringer Ingelheim, AbbVie, Genentech, Mylan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antiretroviral Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antiretroviral Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antiretroviral Agent Market growing?

Ans: The Antiretroviral Agent Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Antiretroviral Agent Market size in 2031?

Ans: The Antiretroviral Agent Market size in 2031 will be US$ 65260 million.

Who are the main players in the Antiretroviral Agent Market report?

Ans: The main players in the Antiretroviral Agent Market are ViiV Healthcare, Gilead Sciences, GlaxoSmithKline, Merck Sharp and Dohme, Bristol-Myers Squibb, Janssen Pharmaceuticals, Pfizer, Boehringer Ingelheim, AbbVie, Genentech, Mylan

What are the Application segmentation covered in the Antiretroviral Agent Market report?

Ans: The Applications covered in the Antiretroviral Agent Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Antiretroviral Agent Market report?

Ans: The Types covered in the Antiretroviral Agent Market report are Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, HIV Integrase Strand Transfer Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Entry Inhibitors—CCR5 Co-Receptor Antagonist, Fusion Inhibitors, Others

1 Antiretroviral Agent Market Overview
1.1 Product Definition
1.2 Antiretroviral Agent by Type
1.2.1 Global Antiretroviral Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Protease Inhibitors
1.2.4 HIV Integrase Strand Transfer Inhibitors
1.2.5 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.6 Entry Inhibitors—CCR5 Co-Receptor Antagonist
1.2.7 Fusion Inhibitors
1.2.8 Others
1.3 Antiretroviral Agent by Application
1.3.1 Global Antiretroviral Agent Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Antiretroviral Agent Market Size Estimates and Forecasts
1.4.1 Global Antiretroviral Agent Revenue 2020-2031
1.4.2 Global Antiretroviral Agent Sales 2020-2031
1.4.3 Global Antiretroviral Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antiretroviral Agent Market Competition by Manufacturers
2.1 Global Antiretroviral Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antiretroviral Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antiretroviral Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antiretroviral Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antiretroviral Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiretroviral Agent, Product Type & Application
2.7 Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
2.8 Global Antiretroviral Agent Market Competitive Situation and Trends
2.8.1 Global Antiretroviral Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antiretroviral Agent Players Market Share by Revenue
2.8.3 Global Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antiretroviral Agent Market Scenario by Region
3.1 Global Antiretroviral Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antiretroviral Agent Sales by Region: 2020-2031
3.2.1 Global Antiretroviral Agent Sales by Region: 2020-2025
3.2.2 Global Antiretroviral Agent Sales by Region: 2026-2031
3.3 Global Antiretroviral Agent Revenue by Region: 2020-2031
3.3.1 Global Antiretroviral Agent Revenue by Region: 2020-2025
3.3.2 Global Antiretroviral Agent Revenue by Region: 2026-2031
3.4 North America Antiretroviral Agent Market Facts & Figures by Country
3.4.1 North America Antiretroviral Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antiretroviral Agent Sales by Country (2020-2031)
3.4.3 North America Antiretroviral Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antiretroviral Agent Market Facts & Figures by Country
3.5.1 Europe Antiretroviral Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antiretroviral Agent Sales by Country (2020-2031)
3.5.3 Europe Antiretroviral Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiretroviral Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Antiretroviral Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antiretroviral Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Antiretroviral Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antiretroviral Agent Market Facts & Figures by Country
3.7.1 Latin America Antiretroviral Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antiretroviral Agent Sales by Country (2020-2031)
3.7.3 Latin America Antiretroviral Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiretroviral Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiretroviral Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antiretroviral Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antiretroviral Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antiretroviral Agent Sales by Type (2020-2031)
4.1.1 Global Antiretroviral Agent Sales by Type (2020-2025)
4.1.2 Global Antiretroviral Agent Sales by Type (2026-2031)
4.1.3 Global Antiretroviral Agent Sales Market Share by Type (2020-2031)
4.2 Global Antiretroviral Agent Revenue by Type (2020-2031)
4.2.1 Global Antiretroviral Agent Revenue by Type (2020-2025)
4.2.2 Global Antiretroviral Agent Revenue by Type (2026-2031)
4.2.3 Global Antiretroviral Agent Revenue Market Share by Type (2020-2031)
4.3 Global Antiretroviral Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antiretroviral Agent Sales by Application (2020-2031)
5.1.1 Global Antiretroviral Agent Sales by Application (2020-2025)
5.1.2 Global Antiretroviral Agent Sales by Application (2026-2031)
5.1.3 Global Antiretroviral Agent Sales Market Share by Application (2020-2031)
5.2 Global Antiretroviral Agent Revenue by Application (2020-2031)
5.2.1 Global Antiretroviral Agent Revenue by Application (2020-2025)
5.2.2 Global Antiretroviral Agent Revenue by Application (2026-2031)
5.2.3 Global Antiretroviral Agent Revenue Market Share by Application (2020-2031)
5.3 Global Antiretroviral Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ViiV Healthcare
6.1.1 ViiV Healthcare Company Information
6.1.2 ViiV Healthcare Description and Business Overview
6.1.3 ViiV Healthcare Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ViiV Healthcare Antiretroviral Agent Product Portfolio
6.1.5 ViiV Healthcare Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences Antiretroviral Agent Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Antiretroviral Agent Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Merck Sharp and Dohme
6.4.1 Merck Sharp and Dohme Company Information
6.4.2 Merck Sharp and Dohme Description and Business Overview
6.4.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Sharp and Dohme Antiretroviral Agent Product Portfolio
6.4.5 Merck Sharp and Dohme Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Company Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bristol-Myers Squibb Antiretroviral Agent Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 Janssen Pharmaceuticals
6.6.1 Janssen Pharmaceuticals Company Information
6.6.2 Janssen Pharmaceuticals Description and Business Overview
6.6.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio
6.6.5 Janssen Pharmaceuticals Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Antiretroviral Agent Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Company Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Boehringer Ingelheim Antiretroviral Agent Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 AbbVie
6.9.1 AbbVie Company Information
6.9.2 AbbVie Description and Business Overview
6.9.3 AbbVie Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AbbVie Antiretroviral Agent Product Portfolio
6.9.5 AbbVie Recent Developments/Updates
6.10 Genentech
6.10.1 Genentech Company Information
6.10.2 Genentech Description and Business Overview
6.10.3 Genentech Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Genentech Antiretroviral Agent Product Portfolio
6.10.5 Genentech Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Company Information
6.11.2 Mylan Description and Business Overview
6.11.3 Mylan Antiretroviral Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mylan Antiretroviral Agent Product Portfolio
6.11.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiretroviral Agent Industry Chain Analysis
7.2 Antiretroviral Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiretroviral Agent Production Mode & Process Analysis
7.4 Antiretroviral Agent Sales and Marketing
7.4.1 Antiretroviral Agent Sales Channels
7.4.2 Antiretroviral Agent Distributors
7.5 Antiretroviral Agent Customer Analysis
8 Antiretroviral Agent Market Dynamics
8.1 Antiretroviral Agent Industry Trends
8.2 Antiretroviral Agent Market Drivers
8.3 Antiretroviral Agent Market Challenges
8.4 Antiretroviral Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ViiV Healthcare
Gilead Sciences
GlaxoSmithKline PLC
Merck Sharp and Dohme
Bristol–Myers Squibb
Janssen Pharmaceuticals
Pfizer Inc
Boehringer Ingelheim
AbbVie
Genentech Inc
Mylan NV
List of Tables
 Table 1. Global Antiretroviral Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antiretroviral Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antiretroviral Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antiretroviral Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antiretroviral Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antiretroviral Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antiretroviral Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antiretroviral Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antiretroviral Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antiretroviral Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antiretroviral Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Antiretroviral Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antiretroviral Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antiretroviral Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antiretroviral Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antiretroviral Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Antiretroviral Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antiretroviral Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Antiretroviral Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antiretroviral Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Antiretroviral Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antiretroviral Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Antiretroviral Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antiretroviral Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antiretroviral Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antiretroviral Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antiretroviral Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antiretroviral Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antiretroviral Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antiretroviral Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antiretroviral Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antiretroviral Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antiretroviral Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antiretroviral Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antiretroviral Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antiretroviral Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antiretroviral Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antiretroviral Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antiretroviral Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antiretroviral Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antiretroviral Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antiretroviral Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antiretroviral Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antiretroviral Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antiretroviral Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antiretroviral Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antiretroviral Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antiretroviral Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Antiretroviral Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Antiretroviral Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Antiretroviral Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Antiretroviral Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antiretroviral Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antiretroviral Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Antiretroviral Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Antiretroviral Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antiretroviral Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antiretroviral Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Antiretroviral Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Antiretroviral Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Antiretroviral Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Antiretroviral Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antiretroviral Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antiretroviral Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Antiretroviral Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Antiretroviral Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antiretroviral Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. ViiV Healthcare Company Information
 Table 71. ViiV Healthcare Description and Business Overview
 Table 72. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. ViiV Healthcare Antiretroviral Agent Product
 Table 74. ViiV Healthcare Recent Developments/Updates
 Table 75. Gilead Sciences Company Information
 Table 76. Gilead Sciences Description and Business Overview
 Table 77. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Gilead Sciences Antiretroviral Agent Product
 Table 79. Gilead Sciences Recent Developments/Updates
 Table 80. GlaxoSmithKline Company Information
 Table 81. GlaxoSmithKline Description and Business Overview
 Table 82. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GlaxoSmithKline Antiretroviral Agent Product
 Table 84. GlaxoSmithKline Recent Developments/Updates
 Table 85. Merck Sharp and Dohme Company Information
 Table 86. Merck Sharp and Dohme Description and Business Overview
 Table 87. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Sharp and Dohme Antiretroviral Agent Product
 Table 89. Merck Sharp and Dohme Recent Developments/Updates
 Table 90. Bristol-Myers Squibb Company Information
 Table 91. Bristol-Myers Squibb Description and Business Overview
 Table 92. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bristol-Myers Squibb Antiretroviral Agent Product
 Table 94. Bristol-Myers Squibb Recent Developments/Updates
 Table 95. Janssen Pharmaceuticals Company Information
 Table 96. Janssen Pharmaceuticals Description and Business Overview
 Table 97. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Janssen Pharmaceuticals Antiretroviral Agent Product
 Table 99. Janssen Pharmaceuticals Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Antiretroviral Agent Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Boehringer Ingelheim Company Information
 Table 106. Boehringer Ingelheim Description and Business Overview
 Table 107. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Boehringer Ingelheim Antiretroviral Agent Product
 Table 109. Boehringer Ingelheim Recent Developments/Updates
 Table 110. AbbVie Company Information
 Table 111. AbbVie Description and Business Overview
 Table 112. AbbVie Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AbbVie Antiretroviral Agent Product
 Table 114. AbbVie Recent Developments/Updates
 Table 115. Genentech Company Information
 Table 116. Genentech Description and Business Overview
 Table 117. Genentech Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Genentech Antiretroviral Agent Product
 Table 119. Genentech Recent Developments/Updates
 Table 120. Mylan Company Information
 Table 121. Mylan Description and Business Overview
 Table 122. Mylan Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Mylan Antiretroviral Agent Product
 Table 124. Mylan Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Antiretroviral Agent Distributors List
 Table 128. Antiretroviral Agent Customers List
 Table 129. Antiretroviral Agent Market Trends
 Table 130. Antiretroviral Agent Market Drivers
 Table 131. Antiretroviral Agent Market Challenges
 Table 132. Antiretroviral Agent Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antiretroviral Agent
 Figure 2. Global Antiretroviral Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiretroviral Agent Market Share by Type: 2024 & 2031
 Figure 4. Nucleoside Reverse Transcriptase Inhibitors Product Picture
 Figure 5. Protease Inhibitors Product Picture
 Figure 6. HIV Integrase Strand Transfer Inhibitors Product Picture
 Figure 7. Non-Nucleoside Reverse Transcriptase Inhibitors Product Picture
 Figure 8. Entry Inhibitors—CCR5 Co-Receptor Antagonist Product Picture
 Figure 9. Fusion Inhibitors Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Antiretroviral Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Antiretroviral Agent Market Share by Application: 2024 & 2031
 Figure 13. Hospital Pharmacies
 Figure 14. Retail Pharmacies
 Figure 15. Online Pharmacies
 Figure 16. Others
 Figure 17. Global Antiretroviral Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Antiretroviral Agent Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Antiretroviral Agent Sales (2020-2031) & (K Units)
 Figure 20. Global Antiretroviral Agent Average Price (US$/Unit) & (2020-2031)
 Figure 21. Antiretroviral Agent Report Years Considered
 Figure 22. Antiretroviral Agent Sales Share by Manufacturers in 2024
 Figure 23. Global Antiretroviral Agent Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Antiretroviral Agent Players: Market Share by Revenue in Antiretroviral Agent in 2024
 Figure 25. Antiretroviral Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Antiretroviral Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Antiretroviral Agent Sales Market Share by Country (2020-2031)
 Figure 28. North America Antiretroviral Agent Revenue Market Share by Country (2020-2031)
 Figure 29. United States Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Antiretroviral Agent Sales Market Share by Country (2020-2031)
 Figure 32. Europe Antiretroviral Agent Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Antiretroviral Agent Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Antiretroviral Agent Revenue Market Share by Region (2020-2031)
 Figure 40. China Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Antiretroviral Agent Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Antiretroviral Agent Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Antiretroviral Agent Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Antiretroviral Agent Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Antiretroviral Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Antiretroviral Agent by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Antiretroviral Agent by Type (2020-2031)
 Figure 61. Global Antiretroviral Agent Price (US$/Unit) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Antiretroviral Agent by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Antiretroviral Agent by Application (2020-2031)
 Figure 64. Global Antiretroviral Agent Price (US$/Unit) by Application (2020-2031)
 Figure 65. Antiretroviral Agent Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global HIV Antiretroviral Drug Market Research Report 2025
Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Retroviral Drugs Market Research Report 2024
Global Long acting Anti HIV Drug Market Research Report 2024
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Therapy Drug Market Research Report 2025
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Clinical Trials Market Research Report 2025
Global Anti AIDs Drug Market Insights Forecast to 2030
Drugs for HIV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV and AIDS Clinical Trials Market Research Report 2025
Global Ritonavir Drug Market Research Report 2024
Global Anti infectious Disease Drugs Market Research Report 2025
HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Antiviral Drugs Market
Direct acting Antiviral Drugs Market
Global Long acting Anti HIV Drugs Market Research Report 2024
Global Efavirenz Tenofovir Emtricitabine Combination Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions